U.S. Exchanges

List of Publicly Traded Wearable Technology Stocks

Comprehensive directory and market analysis of the wearable technology sector, featuring 2026 performance data for healthtech leaders and AR pioneers.

$324B 2032 Market Est.
17.8% Industry CAGR
65 Top AI Score (AXON)
Apr 2026 Last Updated
This page is for informational and educational purposes only and does not constitute investment advice. Always consult a qualified financial professional before making investment decisions.

The 2026 landscape for the List of Publicly Traded Wearable Technology Stocks is defined by a massive shift toward clinical-grade health monitoring and enterprise AR solutions. As the industry accelerates toward a projected $324 billion valuation by 2032, investors are increasingly focusing on specialized enablers within the all tech companies ecosystem. To effectively evaluate these high-beta entities, many utilize our compare wearables tool to benchmark AI fundamental scores against market performance. Whether you are tracking the health & fitness sector for medical device breakthroughs or seeking pure tech growth, understanding the convergence of sensors and semiconductors is critical. This directory outlines the U.S.-listed innovators currently defining the wearable economy.

Key Takeaways

01 Healthtech Growth Engine

Medical wearables are the fastest-growing subsegment, with a 17.8% CAGR driven by real-time glucose and cardiac monitoring advancements.

02 AI Integration Premium

The market currently rewards companies with high AI fundamental scores, such as Axon Enterprise, which leads with an AI score of 65 in 2026.

03 Enterprise AR Pivot

Specialists like Vuzix smartglasses are gaining significant traction in industrial and medical training, moving beyond consumer entertainment.

04 Ecosystem Dominance

Massive platforms like the Apple iWatch leverage deep software ecosystems to maintain consumer loyalty while smaller players compete on high-beta innovation.

Top List of Publicly Traded Wearable Technology Stocks by Market Cap (2026)

The following table tracks the leading wearable technology stocks by April 2026 market valuation, AI fundamental scores, and recent price performance.

Rank Ticker Company Focus Market Cap Price AI Score 3mo Return
1AXONAxon EnterpriseSafety/Bodycams$34.1B$450.4665-22.8%
2DXCMDexcomGlucose Monitors$46.2B$118.4258+14.2%
3GRMNGarmin Ltd.Fitness/GPS$31.5B$162.1552+21.5%
4GENGen DigitalSoftware/Security$11.8B$18.9756-2.1%
5IRTCiRhythm TechCardiac Monitors$3.2B$104.5048+5.4%
6VUZIVuzix Corp.Smartglasses$142M$2.2543-33.0%
7KOPNKopin Corp.Display Tech$84M$0.6539-12.4%
8WLDSWearable DevicesGesture Control$5.3M$9.4241+16.1%
Market data is approximate and for informational purposes only. Data reflects early Q2 2026 figures. Not a recommendation to buy or sell.

List of Publicly Traded Wearable Technology Stocks — Complete Company List

List of Publicly Traded Wearable Technology Stocks Listed on Major U.S. Exchanges

Wearable Technology: Large-Cap Stocks

Wearable Technology: Mid-Cap Stocks

  • DexCom, Inc. (DXCM) (Glucose monitoring systems)
  • Fitbit Inc. (FIT) (IPO in June 2015: health and fitness trackers; track users’ active minutes, calories burned, daily steps, distance traveled, floors climbed, heart rate, measure sleep duration)
  • Garmin Ltd. (GRMN) (GPS enabled products: fixed-mount, hand-held, portable, wrist-based; active trackers and smartwatches)
  • GoPro, Inc. (GPRO) (Action cameras and capture devices)

Wearable Technology: Small-Cap Stocks

Wearable Technology: Micro-Cap Stocks

Risks & Considerations

Rapid Obsolescence Cycles

Wearable hardware requires constant R&D. Companies that fail to iterate annually risk rapid consumer attrition to rivals with superior battery life or sensor accuracy.

Regulatory Compliance Hurdles

Medical wearables are subject to stringent FDA oversight. Delays in clinical validation or failure to secure 510(k) clearances can lead to multi-year revenue droughts.

Data Privacy & Cybersecurity

As wearables collect increasingly sensitive biometric data, they become primary targets for cyberattacks. A major breach can cause irreparable brand damage and legal liability.

High Beta & Market Volatility

Pure-play wearable stocks, especially in the microcap tier like Wearable Devices (WLDS), often experience extreme price swings on minimal news volume or retail sentiment shifts.

These risk factors are for educational purposes only and are not exhaustive. Individual investment decisions should be based on thorough due diligence.

Frequently Asked Questions

Axon Enterprise (AXON) leads the sector with a top AI fundamental score, while Garmin smartwatches (GRMN) have shown strong +21.5% recent returns. For medical focus, Dexcom remains a high-conviction play.
Apple (AAPL), Garmin (GRMN), and Alphabet (GOOG via Fitbit) maintain the largest market shares. Their growth is underpinned by wearable semiconductor enablers like Qualcomm (QCOM).
Vuzix (VUZI) and Kopin (KOPN) are the primary U.S.-listed pure-plays focusing on enterprise AR headsets. Consumer AR is currently dominated by ecosystem giants like Apple and Meta.
The market is projected to reach $324 billion by 2032, growing at a 17.8% CAGR. Health monitoring is currently the fastest-growing segment within this total addressable market.
Vuzix (VUZI) is currently trading at approximately $2.25. While it has seen recent daily gains of 7%, the stock remains volatile with an AI fundamental score of 43 in early 2026.
Garmin (GRMN) has shown superior recent returns (+21.5%) by focusing on specialized fitness and GPS niches. Apple offers less volatility due to its massive ecosystem scale and semiconductor vertical integration.
Yes, Wearable Devices (WLDS) with a $5.3M market cap is a notable microcap play. These stocks offer high-beta potential but carry significantly higher risk of capital loss than established mid-caps.
Clinical health monitoring is the leader, growing at nearly 18% annually. Stocks like Dexcom and iRhythm are primary beneficiaries of the shift toward preventative digital healthcare.
Last updated April 2026 · Data sourced from U.S. exchange filings